Rapid Micro Biosystems (RPID) Cash from Operations (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -363.89% |
| Dec 31, 2025 | 64.14% |
| Sep 30, 2025 | 6.69% |
| Jun 30, 2025 | -7.00% |
| Mar 31, 2025 | 8.52% |
| Dec 31, 2024 | -15.22% |
| Sep 30, 2024 | 15.01% |
| Jun 30, 2024 | 34.82% |
| Mar 31, 2024 | -63.47% |
| Dec 31, 2023 | 2.17% |
| Sep 30, 2023 | -5.64% |
| Jun 30, 2023 | 44.92% |
| Mar 31, 2023 | -43.17% |
| Dec 31, 2022 | 22.84% |
| Sep 30, 2022 | -0.79% |
| Jun 30, 2022 | 10.80% |
| Mar 31, 2022 | -30.37% |
| Dec 31, 2021 | 33.26% |
| Sep 30, 2021 | -67.82% |
| Jun 30, 2021 | -2.17% |
| Mar 31, 2021 | -117.79% |
| Dec 31, 2020 | 41.35% |